StocksTelegraph
S&P 500NASDAQDOWRUSSELL
NASDAQ · PSNL·Healthcare

Personalis, Inc. Stock Analysis & AI Score

Market Open
$16.40
Prev Close
Market Cap
Day Range
52W Range
P/E
EPS (TTM)
Volume
Avg —
Beta
40
ST Score
39.6/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees
CEO
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date
Website
Country
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

PSNL
39.6out of 100
Grade C

Personalis, Inc. (PSNL) holds an ST Score of 39.6 out of 100 (C), with its strongest factor being Financial Strength (A+) and its weakest Profitability (F). Analysts rate PSNL Buy across 12 ratings with a $14.95 average price target (-0.1% vs the current $16.40).

Strongest
Financial StrengthA+
Weakest
ProfitabilityF
All factor grades
  • Financial StrengthA+
  • MomentumB+
  • ValuationB-
  • GrowthD+
  • ForecastD+
  • ProfitabilityF
  • Piotroski1/9
Score methodology
Press Releases

Contact

PSNL stock: frequently asked questions

What is PSNL's ST Score?

Personalis, Inc. (PSNL) has an ST Score of 39.6 out of 100, an overall grade of C. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is PSNL a buy, sell, or hold?

Wall Street's consensus rating on PSNL is Buy based on 12 analyst ratings. Our own ST Score grades it C (39.6/100). This is data, not investment advice — always do your own research.

What is PSNL's valuation grade?

Personalis, Inc. (PSNL) earns a valuation grade of B-, measured against Medical - Diagnostics & Research peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is PSNL's growth grade?

Personalis, Inc. (PSNL) earns a growth grade of D+, measured against Medical - Diagnostics & Research peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is PSNL's profitability grade?

Personalis, Inc. (PSNL) earns a profitability grade of F, measured against Medical - Diagnostics & Research peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is PSNL's financial strength grade?

Personalis, Inc. (PSNL) earns a financial strength grade of A+, measured against Medical - Diagnostics & Research peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for PSNL?

The average analyst price target for Personalis, Inc. (PSNL) is $14.95 from 12 analysts, which is -0.1% versus the recent price of $16.40.

What is PSNL's Piotroski score?

Personalis, Inc. (PSNL) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.